The initial attempts to selectively induce apoptosis in cancer cells focused on fusing TRAIL derivatives to various molecules, primarily antibodies or their fragments targeting tumor-associated cell surface molecules (Table 1). The gene discussed is TNFSF10; the disease is cancer.